OPGN - OpGen, Inc.
NASDAQ
->
Healthcare
->
Diagnostics & Research
Rockville,
United States
Type: Equity
OPGN price evolution
OPGN
| (in millions $) | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $0.29 | $3.24 | $7.04 | $7.44 |
| Short term investments | ||||
| Net receivables | $0.42 | $0.62 | $0.67 | $0.51 |
| Inventory | $2.81 | $3.34 | $3.64 | $1.35 |
| Total current assets | $3.45 | $7.23 | $10.74 | $10.66 |
| Long term investments | ||||
| Property, plant & equipment | $5.74 | $5.89 | $5.81 | $4.92 |
| Goodwill & intangible assets | $6.84 | $7.21 | $7.4 | $7.44 |
| Total noncurrent assets | $14.68 | $15.21 | $15.77 | $15.16 |
| Total investments | ||||
| Total assets | $18.13 | $22.43 | $26.51 | $25.81 |
| Current liabilities | ||||
| Accounts payable | $0.9 | $0.2 | $0.27 | $0.42 |
| Deferred revenue | $0.19 | $0.03 | $0.05 | $0.14 |
| Short long term debt | $9.72 | $9.71 | $5.46 | $7.4 |
| Total current liabilities | $12.47 | $12.42 | $8.64 | $10.59 |
| Long term debt | $2.83 | $2.99 | $8.48 | $4.85 |
| Total noncurrent liabilities | $2.99 | $3.16 | $8.7 | $7.65 |
| Total debt | $12.55 | $12.7 | $13.94 | $14.82 |
| Total liabilities | $15.46 | $15.58 | $17.33 | $18.24 |
| Shareholders' equity | ||||
| Retained earnings | -$288.45 | -$284.39 | -$278.56 | -$272.82 |
| Other shareholder equity | -$0.68 | -$0.76 | -$0.64 | -$0.8 |
| Total shareholder equity | $2.68 | $6.86 | $9.18 | $7.58 |
| (in millions $) | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $7.44 | $36.08 | $13.36 | $2.71 |
| Short term investments | $2.52 | |||
| Net receivables | $0.51 | $1.17 | $0.65 | $0.57 |
| Inventory | $1.35 | $4.71 | $3.17 | $0.47 |
| Total current assets | $10.66 | $39.74 | $16.89 | $6.67 |
| Long term investments | ||||
| Property, plant & equipment | $4.92 | $5.92 | $5.79 | $2.13 |
| Goodwill & intangible assets | $7.44 | $21.98 | $24.61 | $1.42 |
| Total noncurrent assets | $15.16 | $31.92 | $32.86 | $3.75 |
| Total investments | $2.52 | |||
| Total assets | $25.81 | $71.67 | $49.75 | $10.42 |
| Current liabilities | ||||
| Accounts payable | $0.42 | $1.31 | $1.87 | $1.06 |
| Deferred revenue | $0.14 | $0.01 | $0.01 | |
| Short long term debt | $7.4 | $15.02 | $1.93 | $1.97 |
| Total current liabilities | $10.59 | $19.92 | $7.37 | $4.94 |
| Long term debt | $4.85 | $10.16 | $20.92 | $1.19 |
| Total noncurrent liabilities | $7.65 | $10.53 | $21.19 | $1.19 |
| Total debt | $14.82 | $25.18 | $22.85 | $3.16 |
| Total liabilities | $18.24 | $30.45 | $28.56 | $6.13 |
| Shareholders' equity | ||||
| Retained earnings | -$272.82 | -$235.54 | -$200.74 | -$174.52 |
| Other shareholder equity | -$0.8 | $0.59 | $2.55 | -$0.02 |
| Total shareholder equity | $7.58 | $41.22 | $21.19 | $4.29 |
| (in millions $) | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $0.7 | $0.74 | $0.91 | $0.72 |
| Cost of revenue | $0.69 | $0.92 | $0.72 | $0.54 |
| Gross Profit | $0.01 | -$0.18 | $0.19 | $0.19 |
| Operating activities | ||||
| Research & development | $1.2 | $1.39 | $1.81 | $1.55 |
| Selling, general & administrative | $2.37 | $3.59 | $3.45 | $3.2 |
| Total operating expenses | $3.57 | $4.97 | $5.26 | $10.12 |
| Operating income | -$3.57 | -$5.16 | -$5.07 | -$9.94 |
| Income from continuing operations | ||||
| EBIT | -$3.67 | -$5.14 | -$5.12 | -$9.9 |
| Income tax expense | ||||
| Interest expense | $0.4 | $0.68 | $0.62 | $0.64 |
| Net income | ||||
| Net income | -$4.06 | -$5.83 | -$5.74 | -$10.54 |
| Income (for common shares) | -$4.06 | -$5.83 | -$5.74 | -$10.54 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2.61 | $4.31 | $4.21 | $3.5 |
| Cost of revenue | $3.42 | $2.85 | $3.85 | $1.63 |
| Gross Profit | -$0.82 | $1.46 | $0.37 | $1.87 |
| Operating activities | ||||
| Research & development | $8.17 | $10.91 | $9.96 | $5.12 |
| Selling, general & administrative | $13.23 | $13.65 | $11.9 | $7.72 |
| Total operating expenses | $33.75 | $24.73 | $23.08 | $14.14 |
| Operating income | -$34.57 | -$23.27 | -$22.72 | -$12.27 |
| Income from continuing operations | ||||
| EBIT | -$34.03 | -$29.96 | -$22.68 | -$12.26 |
| Income tax expense | $0.04 | $0.13 | ||
| Interest expense | $3.26 | $4.8 | $3.4 | $0.19 |
| Net income | ||||
| Net income | -$37.28 | -$34.81 | -$26.21 | -$12.45 |
| Income (for common shares) | -$37.28 | -$41.97 | -$26.21 | -$12.45 |
| (in millions $) | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Net income | -$4.06 | -$5.83 | -$5.74 | -$10.54 |
| Operating activities | ||||
| Depreciation | $0.35 | $0.37 | $0.35 | $0.34 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | -$0.23 | $0.44 | $0.21 | $0.22 |
| Total cash flows from operations | -$2.93 | -$4.75 | -$4.96 | -$3.99 |
| Investing activities | ||||
| Capital expenditures | -$0.1 | -$0.37 | -$0.33 | -$0.4 |
| Investments | ||||
| Total cash flows from investing | -$0.1 | -$0.37 | -$0.33 | -$0.4 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.03 | $3.18 | $6.97 | $3.08 |
| Net borrowings | -$0 | -$1.68 | -$2.23 | -$2.07 |
| Total cash flows from financing | $0.03 | $1.5 | $4.74 | $1.01 |
| Effect of exchange rate | $0.05 | -$0.19 | $0.15 | $0.63 |
| Change in cash and equivalents | -$2.95 | -$3.8 | -$0.4 | -$2.76 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | -$37.28 | -$34.81 | -$26.21 | -$12.45 |
| Operating activities | ||||
| Depreciation | $1.64 | $2.71 | $2.33 | $0.92 |
| Business acquisitions & disposals | $1.27 | |||
| Stock-based compensation | $0.95 | $0.88 | $0.32 | $0.37 |
| Total cash flows from operations | -$20.45 | -$21.48 | -$23.4 | -$11.51 |
| Investing activities | ||||
| Capital expenditures | -$0.59 | -$1.98 | -$0.13 | -$0 |
| Investments | -$2.2 | -$2.5 | ||
| Total cash flows from investing | -$0.59 | -$1.98 | -$1.06 | -$2.5 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $4.07 | $34.31 | $33.79 | $13.06 |
| Net borrowings | -$10.81 | -$0.71 | $0.29 | -$0.89 |
| Total cash flows from financing | -$6.74 | $47.45 | $34.09 | $12.17 |
| Effect of exchange rate | -$0.92 | -$1.46 | $1.59 | -$0 |
| Change in cash and equivalents | -$28.7 | $22.52 | $11.21 | -$1.84 |
News
Fundamentals
| Market cap | $6.31M |
|---|---|
| Enterprise value | $18.57M |
| Shares outstanding | 10.01M |
| Revenue | $3.07M |
|---|---|
| EBITDA | -$22.42M |
| EBIT | -$23.83M |
| Net Income | -$26.16M |
| Revenue Q/Q | 55.78% |
| Revenue Y/Y | -7.28% |
| P/E ratio | -0.24 |
|---|---|
| EV/Sales | 6.05 |
| EV/EBITDA | -0.83 |
| EV/EBIT | -0.78 |
| P/S ratio | 2.05 |
| P/B ratio | 1.88 |
| Book/Share | 0.33 |
| Cash/Share | 0.03 |
| EPS | -$2.61 |
|---|---|
| ROA | -112.65% |
| ROE | -398.06% |
| Debt/Equity | 2.41 |
|---|---|
| Net debt/EBITDA | -0.68 |
| Current ratio | 0.28 |
| Quick ratio | 0.05 |